Economic Burden Is Greater Among Patients With Ovarian Cancer Receiving BRCA Testing
Ovarian Cancer Awareness Month Draws Attention to Uneven Declines in Mortality
Interval Cytoreductive Surgery Following Neoadjuvant Chemotherapy Improves Advanced Ovarian Cancer Outcomes
Missed Opportunities for Salpingectomy Highlight Gaps in Ovarian Cancer Prevention
Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer
Investigators Call for Greater Awareness, Further Research to Reduce Ovarian Cancer Mortality Disparities
Investigators Identify Factors Behind US Ovarian Cancer Mortality Disparities, Propose Targeted Solutions
Improved Treatments, Prevention Drive Drop in US Ovarian Cancer Mortality: Muhammad Faizan, MBBS
Older, White, and Rural Women Remain at Risk Despite Decline in US Ovarian Cancer Mortality: Muhammad Faizan, MBBS
Evaluating Long-Term Safety Considerations for Targeted Therapies in Ovarian Cancer
The Effect of Adverse Event Profiles on Treatment Decisions
Streamlining Biomarker-Driven Therapy Decisions to Prevent Delays
The Importance of Multidisciplinary Collaboration in the Management of Ovarian Cancer
Overcoming Payer-Related Barriers for Optimal Care in Patients With Ovarian Cancer
ROSELLA Trial Highlights Safe, Biomarker-Free Option for Platinum-Resistant Ovarian Cancer: Brian Slomovitz, MD
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care